TNF and Miyoshi myopathy: The biological pathways involved in hematological malignancies and UC are interlinked, as numerous mediators of inflammation, such as tumor necrosis factor-alpha, nuclear factor kappa-light-chain-enhancer of activated B cells, and interleukins, are shared key components of the pathogenesis of both MM and UC [33,34].